TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2023

A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.

Min Chul Kim et al.PubMed ↗Full text ↗Publisher ↗

The primary results report of NCT04074551.

No numbers read from the abstract.